Helen Heslop
Direktor/Vorstandsmitglied bei The Leukemia & Lymphoma Society, Inc.
Aktive Positionen von Helen Heslop
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
The Leukemia & Lymphoma Society, Inc.
 The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY. | Direktor/Vorstandsmitglied | 01.07.2023 | - |
| Dan L. Duncan Comprehensive Cancer Center | Corporate Officer/Principal | - | - |
| Center For Cell & Gene Therapy | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Helen Heslop
Ehemalige bekannte Positionen von Helen Heslop
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ALLOVIR, INC. | Gründer | 01.08.2013 | - |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Founder | 2 |
| Director/Board Member | 2 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 2 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ALLOVIR, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
The Leukemia & Lymphoma Society, Inc.
The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY. | Commercial Services |
| Dan L. Duncan Comprehensive Cancer Center | |
| Center For Cell & Gene Therapy |
- Börse
- Insiders
- Helen Heslop
- Erfahrung
